CERVOMED INC

CRVO · NASDAQ

Updated at 2026-10-15 08:28:24

$2.29+0.88%
Today's High
$2.41
Today’s Low
$2.13
CERVOMED INC (CRVO) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$2.22
Previous Close
$2.29
Volume
497.19K
Market Cap
$34.62M
P/E Ratio
--
EPS
$-3.21

Previous Day Range

$2.13$2.41

52-Week Range

$2.13$10.00

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
20 PARK PLAZA, BOSTON, MA, UNITED STATES, 02116
Country
US
Listing Date
2016-11-09
Fiscal Year End
December
Shares Outstanding
13.53M
CIK
0001053691

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. The company is headquartered in Boston, Massachusetts.

Financial Metrics

Revenue

2026-06-30

$0

2026-03-31

$0

2025-12-31

$8.72K

2025-09-30

$322.56K

Operating Expenses

2026-06-30

$6.67M

2026-03-31

$8.11M

2025-12-31

$8.33M

2025-09-30

$8.36M

Net Income

2026-06-30

-$6.57M

2026-03-31

-$7.96M

2025-12-31

-$8.08M

2025-09-30

-$7.72M

Net Profit Margin

2026-06-30

--

2026-03-31

--

2025-12-31

-92.68K%

2025-09-30

-2.39K%

Earnings Per Share

2026-06-30

$-0.64

2026-03-31

$-0.86

2025-12-31

$-0.88

2025-09-30

$-0.84

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$6.57M

2026-03-31

-$7.96M

2025-12-31

-$8.08M

2025-09-30

-$7.72M

Effective Tax Rate

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.